Literature DB >> 23498382

Decision making for participation in dementia research.

Betty S Black1, Malory Wechsler, Linda Fogarty.   

Abstract

OBJECTIVES: This study examined the decision-making process used by individuals asked to participate in dementia research and their opinions on how future proxy research decisions would or should be made, including participants' preferred ethical standards for decision making.
DESIGN: Cross-sectional qualitative methods.
SETTING: University research institutions. PARTICIPANTS: Informants were 39 of 46 individuals with cognitive impairment (i.e., subjects) who were asked to join one of six dementia studies and 46 study partners or surrogate decision makers. MEASUREMENTS: Semistructured individual interviews were audio recorded and transcribed for content analysis.
RESULTS: Within dyads, subjects and surrogates often differed in their perspectives on how decisions were made regarding whether to join a study, and no single method was identified as a predominant approach. Although there was only fair agreement within dyads on who ultimately made the decision, subjects and surrogates most often said it was the subject. For future proxy research decisions, subjects and surrogates most often preferred the ethical standard of best interests and least often favored substituted judgment. However, many participants preferred a combination of best interests and substituted judgment or a more complex approach that also considers the interests of others.
CONCLUSIONS: Individuals with mild to moderate cognitive impairment can and do engage to some extent in the decision-making process for dementia research and can discuss their opinions on how they would want such decisions made for them in the future. These findings support the recommended approach for obtaining proxy consent and subject assent if the individual lacks consent capacity.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23498382      PMCID: PMC3381948          DOI: 10.1016/j.jagp.2012.11.009

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  18 in total

1.  Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.

Authors:  Scott Y H Kim; Christopher Cox; Eric D Caine
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

2.  Core safeguards for clinical research with adults who are unable to consent.

Authors:  D Wendler; K Prasad
Journal:  Ann Intern Med       Date:  2001-10-02       Impact factor: 25.391

3.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

4.  Identifying dementia in high-risk community samples: the memory and medical care study.

Authors:  Betty Smith Black; Judith Kasper; Jason Brandt; Andrew D Shore; Pearl German; Lynda Burton; Joseph J Gallo; Constantine Lyketsos; Peter V Rabins
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Jan-Mar       Impact factor: 2.703

5.  Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial.

Authors:  Jason H T Karlawish; David J Casarett; Bryan D James
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

6.  How do AD patients and their caregivers decide whether to enroll in a clinical trial?

Authors:  J H Karlawish; D Casarett; J Klocinski; P Sankar
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

7.  Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

Authors:  Lon S Schneider; M Saleem Ismail; Karen Dagerman; Sonia Davis; Jason Olin; Dennis McManus; Eric Pfeiffer; J Michael Ryan; David L Sultzer; Pierre N Tariot
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

8.  When others decide: reasons for allowing patients with Alzheimer's disease to participate in nontherapeutic research.

Authors:  N Lynöe; M Sandlund; L Jacobsson
Journal:  Int Psychogeriatr       Date:  1998-12       Impact factor: 3.878

9.  How proxies make decisions about research for patients with Alzheimer's disease.

Authors:  J Sugarman; C Cain; R Wallace; K A Welsh-Bohmer
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

10.  Dementia care and quality of life in assisted living and nursing homes.

Authors:  Sheryl Zimmerman; Philip D Sloane; Christianna S Williams; Peter S Reed; John S Preisser; J Kevin Eckert; Malaz Boustani; Debra Dobbs
Journal:  Gerontologist       Date:  2005-10
View more
  16 in total

1.  Do human subject safeguards matter to potential participants in psychiatric genetic research?

Authors:  Laura Weiss Roberts; Jane Paik Kim; Tenzin Tsungmey; Laura B Dunn
Journal:  J Psychiatr Res       Date:  2019-06-08       Impact factor: 4.791

2.  Planning Ahead for Dementia Research Participation: Insights from a Survey of Older Australians and Implications for Ethics, Law and Practice.

Authors:  Nola Ries; Elise Mansfield; Rob Sanson-Fisher
Journal:  J Bioeth Inq       Date:  2019-07-11       Impact factor: 1.352

3.  Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Authors:  Betty S Black; Holly A Taylor; Peter V Rabins; Jason Karlawish
Journal:  Dementia (London)       Date:  2016-05-13

4.  A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners.

Authors:  Chelsea G Cox; Mary M Ryan B A; Daniel L Gillen; Joshua D Grill
Journal:  Am J Geriatr Psychiatry       Date:  2018-11-03       Impact factor: 4.105

Review 5.  Reconsidering Gold Standards for Surrogate Decision Making for People with Dementia.

Authors:  James M Wilkins
Journal:  Psychiatr Clin North Am       Date:  2021-12

Review 6.  Evaluation of the capacity to appoint a healthcare proxy.

Authors:  Jennifer Moye; Charles P Sabatino; Rebecca Weintraub Brendel
Journal:  Am J Geriatr Psychiatry       Date:  2013-04       Impact factor: 4.105

7.  Researchers' perspectives on the role of study partners in dementia research.

Authors:  Betty S Black; Holly Taylor; Peter V Rabins; Jason Karlawish
Journal:  Int Psychogeriatr       Date:  2014-07-03       Impact factor: 3.878

8.  Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease.

Authors:  James M Wilkins; Brent P Forester
Journal:  Int J Geriatr Psychiatry       Date:  2020-01-26       Impact factor: 3.485

9.  Ethical and Methodological Considerations for Evaluating Participant Views on Alzheimer's and Dementia Research.

Authors:  Clark Benson; Amanda Friz; Shannon Mullen; Laura Block; Andrea Gilmore-Bykovskyi
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-26       Impact factor: 1.742

Review 10.  Determining medical decision-making capacity in brain tumor patients: why and how?

Authors:  Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven
Journal:  Neurooncol Pract       Date:  2020-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.